Buscar en
Enfermedades Infecciosas y Microbiología Clínica (English Edition)
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica (English Edition) Campylobacter fetus meningitis and subdural empyema
Journal Information
Vol. 40. Issue 4.
Pages 212-213 (April 2022)
Vol. 40. Issue 4.
Pages 212-213 (April 2022)
Scientific letter
Full text access
Campylobacter fetus meningitis and subdural empyema
Meningitis y empiema subdural por Campylobacter fetus
Visits
325
Raquel Fernández Gonzáleza,
Corresponding author
raquelferngonz@gmail.com

Corresponding author.
, Ana María Lorenzo-Vizcayaa, María Bustillo Casadob, Ricardo Fernández-Rodríguezb
a Servicio de Medicina Interna, Hospital Universitario de Ourense, Orense, Spain
b Unidad de Infecciosas, Servicio de Medicina Interna, Hospital Universitario de Ourense, Orense, Spain
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Tables (1)
Table 1. Summary of the cases published to date of meningitis due to Campylobacter fetus.
Additional material (1)
Full Text

Bacterial meningitis is a serious condition that requires early antibiotic therapy. Its most frequent aetiology is Streptococcus pneumoniae and Neisseria meningitidis. It is rare for the responsible pathogen to have an animal reservoir, as is the case of Campylobacter fetus (C. fetus), whose reservoir is the digestive tract of cows and sheep, being a causal pathogen of zoonosis. Here we present a case of meningitis due to C. fetus.

The patient was a 59-year-old male smoker with no history of chronic alcohol consumption, hypertension or dyslipidaemia. He initially sought treatment for vomiting, diarrhoea and abdominal pain. After three days of dietary measures, the symptoms of fever (up to 40 °C), headache, prostration and dysarthria persisted, for which complementary tests were carried out, in which CRP 27.3 mg/dl, procalcitonin 0.4 ng/ml and 9,629 103/ug leukocytes with left shift (86.9% neutrophils) stood out. With the suspicion of infection of the central nervous system, a cranial CT scan was performed, which showed a left frontotemporoparietal hypodense subdural haematoma of 17 mm with deviation from the midline and another right frontotemporoparietal haematoma of 5 mm. With these findings, empirical antibiotic coverage was started with ceftriaxone, ampicillin, linezolid and acyclovir, and urgent surgery was performed with drainage of the collections. Initially, the clinical and radiological course was favourable, with decreased collections and no deviation from the midline, so a lumbar puncture was performed on the third day of antibiotic therapy, with yellowish-looking fluid coming out, with 13 predominantly monomorphonuclear leukocytes (86%), with glucose consumption (52 mg/dl in CSF, capillary glycaemia being 116) with proteinuria (304 mg/dl) and an outlet pressure of 13 mmHg.

One week after admission, the patient began to present a new neurological deterioration consisting of greater dysarthria. EEG with pathological tracing was performed, adjusting anticonvulsant treatment. Growth was detected in the subdural fluid samples sent in blood culture bottles (bioMérieux), so a Gram stain was performed directly from the bottle, this being highly suggestive of Campylobacter spp. Seeding was carried out on PVX (bioMérieux) and COS (bioMérieux) plates with incubation for 24 h and subsequent reincubation for another 24 h with no growth. It was also seeded on Campylosel agar (CAM-bioMérieux), incubating in a hood with GENbox microaer sachets for 48 h, observing growth of colonies, subsequently proceeding to identification with the Vitek MS system (bioMérieux). Sensitivity studies were carried out on Mueller-Hinton 2 agar +5% sheep blood (MHS-bioMérieux) with disc-plate in microaerophilia (in a hood with GENbox micro-bioMérieux sachets), being sensitive to carbapenems, so antibiotic therapy was modified to meropenem 2 g every 8 h, with the patient subsequently presenting a favourable clinical course. Antibiotic therapy was completed for four weeks and the anticonvulsant dose could be lowered until withdrawal. Prior to discharge, a brain MRI was performed, which showed a persistent left parietal subdural haematoma and discreet right meningeal thickening, without clinical repercussions, so no new drainage was performed. In subsequent follow-up, the patient remained asymptomatic.

C. fetus is a gram-negative bacillus found in the digestive tract of cattle and sheep, and can be transmitted after ingestion of contaminated food (such as milk or meat) or after direct contact with infected animals1. However, this contact with infected animals has only been identified in slightly more than half of the case2.

Meningitis due to C. fetus is infrequent (0.02 per million inhabitants) and usually occurs in people with compromised immunity, generally with a history of alcoholism, liver disease, advanced age, diabetes mellitus, corticosteroid treatment or neoplasia1.

The first published case dates back to 1960, and since then 37 cases of meningitis due to C. fetus have been documented (Table 1)1–5, but only two case studies of empyema have been published6,7. Patients’ average age is 50 years, and the majority are male (81%). As a risk factor, 27% have a history of alcoholism, 16% have diabetes mellitus, whilst 43% of cases are healthy patients. Although all the patients presented alterations in the biochemistry of the cerebrospinal fluid, in many cases the culture of the cerebrospinal fluid was negative (in up to 9 cases the only isolation was in blood), whilst the blood culture was positive in 81% of the cases. In 18%, the isolation was only in cerebrospinal fluid. Regarding the outcome, 72% were cured and there were three deaths among the published cases.

Table 1.

Summary of the cases published to date of meningitis due to Campylobacter fetus.

No.  Ref.  Year  Author  Age  Gender  Associated factors  Identification method  Culture  Outcome 
1960  Edwds  50  AHT  BCH  BC CSF  Cured 
1962  Robin  47  Alcoholism  Not described  Not described  Cured 
3,4  1964  Collins  55  CLL  BCH  BC CSF  Unknown 
3,4  1966  Killam  48  Unknown  BCH  BC  Haemiparesis 
3,4  1969  Reyman  69  Diabetes Mellitus  BCH  BC  Died 
                CSF   
1969  Stille  50  Diabetes Mellitus  Not described  Not described  Cured 
1971  Gunderson  53  Drug abuse  BCH  BC  Coma 
3,4  1976  Gubina  46  Unknown  BCH  BC  Cured 
3,4  1976  Gubina  40  Unknown  BCH  BC  Cured 
10  1978  Zelinger  50  Unknown  BCH  BC  Cured 
11  1984  Hanai  53  Liver dysfunction  BCH  BC, CSF  Cured 
12  3,4  1985  Francioli  68  Cancer  BCH  BC, CSF  Died 
13  3,4  1985  Francioli  65  Alcoholic cirrhosis  BCH  BC  Cured 
14  1985  Malbrunot  38  Alcoholism  Not described  BC, CSF  Cured 
15  1986  Lyda  30  Unknown  BCH  CSF  Cured 
16  1986  Lyda  42  Unknown  BCH  CSF  Cured 
17  1986  Yamazaki  53  Unknown  BCH  BC, CSF  Unknown 
18  1986  Yamazaki  53  Unknown  BCH  BC, CSF  Unknown 
19  3,4  1987  Rao  47  Renal treatment  BCH  BC, CSF  Cured 
20  1989  Clavelou  39  Alcoholism  Not described  BC  Cured 
21  3,4  1990  Kato  55  Alcoholism, Diabetes Mellitus  BCH  CSF  Cured 
22  1993  Inoe  40  Unknown  BCH  CSF  Cured 
23  1996  Wlihelm  83  Alcoholic cirrhosis  Not described  BC  Died 
24  3,4  1998  Dronda  47  Alcoholism  API-Campy  BC, CSF  Cured 
              PCR     
25  2002  Ozeki  49  Alcoholic cirrhosis  BCH  BC, CSF  Haemiparesis 
26  3,4  2004  Herve  71  Diabetes Mellitus  API Campy  BC, CSF  Cured 
              GS     
27  2006  Shioyama  43  Unknown  BCH  BC, CSF  Cured 
28  3,4,6  2008  Kanayama  51  Unknown  BCH  BC, CSF  Cured 
29  3,4  2008  Umehara  40  Crohn’s disease  BCH  BC, CSF  Cured 
30  3,4  2010  Martinez  28  Unknown  GS  BC  Cured 
31  3,4  2013  Suy  75  Diabetes Mellitus  GS  BC, CSF  Cured 
32  2,3,4  2016  Van Samkar  23  Unknown  Not described  CSF  Problems concentrating 
33  2,3,4  2016  Van Samkar  52  Unknown  Not described  BC, CSF  Cured 
34  2016  Moon  64  Alcoholism, Diabetes Mellitus  BCH GS  BC  Cured 
35  2017  Ishihara  48  Unknown  MALDI-TOFF  BC, CSF  Cured 
36  2019  Kenta  35  Unknown  GS  BC  Cured 
37  2019  Sho Tbe  56  Alcoholism  Not described  BC, CSF  Cured 
38    2020  Present  59  AHT  MALDI-TOFF  CSF  Cured 

AHT: arterial hypertension, BC: blood cultures, BCH: biochemical, CLL: chronic lymphocytic leukaemia, CSF: cerebrospinal fluid, F: female, GS: genetic sequencing, M: male, PCR: polymerase chain reaction, Ref.; bibliographic reference.

There is no established treatment protocol. In the publications reviewed, many patients were treated with broad-spectrum antibiotic therapy or combination therapy, but there have also been reports of patients cured after monotherapy with ampicillin or amoxicillin3. We could highlight the fact that a multicentre study identified an intermediate sensitivity or resistance of 12% to ampicillin, 80% to cefotaxime and 100% to erythromycin, as well as the fact that there are reported cases of C. fetus strains resistant to ceftriaxone, cefotaxime and penicillin. Some authors recommend treatment with carbapenems, as well as prolonged treatment2,5.

In conclusion, meningitis due to C. fetus is rare, but should not be ruled out even if we are dealing with a healthy patient with no apparent contact with infected animals, especially if associated with a digestive condition. Its treatment would be prolonged antibiotic therapy.

Appendix A
Supplementary data

The following is Supplementary data to this article:

References
[1]
Kenta Ikeda, Yasuhiro Manabe, Shunya Fujiwara, Yoshio Omote, Hisashi Narai, Koji Abe.
Campylobacter fetus meningitis and pyogenic spondylodiscitis in a healthy young woman.
Case Resp Neurol, 11 (2019), pp. 299-330
[2]
A. van Samkar, M.C. Brouwer, A. van der Ende, D. van de Beek.
Campylobacter fetus meningitis in adults report of 2 cases and revise of the literature.
Medicine (Baltimore), 95 (2016),
[3]
S. Tanabe, S. Kutsuna, M. Tsuboi, N. Takeshita, K. Hayakawa, N. Ohmagari.
Meningoencephalitis caused by a Campylobacter fetus in a patient with chronic alcoholism.
Intern Med, 58 (2019), pp. 2247-2250
[4]
A. Ishihara, E. Hashimoto, H. Ishioka, H. Kobayashi, H. Gomi.
Campylobacter fetus meningitis associated with eating habits of raw meat and raw liver in a healthy patient: a case report and literature review.
IDCases, 11 (2018), pp. 97-100
[5]
J. Moon, N. Kim, H.S. Lee, H.R. Shin, S.T. Lee, K.H. Jung, et al.
Campylobacter fetus meningitis confirmed by a 16S rRNA gene analysis using the MinION nanopore sequencer, South Korea, 2016.
Emerg Microbes Infect, 6 (2017), pp. e94
[6]
S. Kanayama, K. Ohnishi, T. Yamaura, M. Katayma, J. Makino, N. Takemura, et al.
Case of bilateral subdural empyema complicationg Campylobacter fetus subspecies fetus meningitis.
Brain Nerve, 60 (2008), pp. 659-662
[7]
M.H. Mendelson, P. Nicholas, M. Malowany, S. Lewin.
Subdural empyema caused by Campylobacter fetus spp. fetus.
J Infect Dis, 153 (1986), pp. 1183-1184

Please cite this article as: Fernández González R, Lorenzo-Vizcaya AM, Bustillo Casado M, Fernández-Rodríguez R. Meningitis y empiema subdural por Campylobacter fetus. Enferm Infecc Microbiol Clin. 2022;40:212–213.

Copyright © 2021. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
Article options
Tools
Supplemental materials
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.eimce.2024.01.011
No mostrar más